SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 69.09 |
| Enterprise Value ($M) | 61.43 |
| Book Value ($M) | 113.62 |
| Book Value / Share | 2.15 |
| Price / Book | 0.61 |
| NCAV ($M) | 100.19 |
| NCAV / Share | 1.88 |
| Price / NCAV | 0.69 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -1.03 |
| Return on Assets (ROA) | -0.56 |
| Return on Equity (ROE) | -0.71 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 7.26 |
| Current Ratio | 7.26 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 134.35 |
| Assets | 147.78 |
| Liabilities | 34.16 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -142.47 |
| Net Income | -134.85 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -121.91 |
| Cash from Investing | 86.26 |
| Cash from Financing | 30.82 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Tang Capital Partners Lp | 6.30 | -18.41 | |
| 13G | HBM Healthcare Investments (Cayman) Ltd. | 6.50 | ||
| 13G/A | Fmr Llc | 3.40 | -69.33 | |
| 13G/A | Orbimed Advisors Llc | 0.00 | -100.00 | |
| 13G/A | Vivo Capital Fund IX, L.P. | 3.40 | ||
| 13G/A | Cormorant Asset Management, LP | 0.00 | -100.00 | |
| 13G/A | Millennium Management Llc | 3.80 | -32.39 | |
| 13D/A | LSV Associates, LLC | 5.90 | -29.92 | |
| 13G/A | Redmile Group, LLC | 9.60 | -1.65 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 1,192,735 | 3,249,279 | 36.71 | |
| 4,385,358 | 13,071,473 | 33.55 | |
| 151,029 | 587,410 | 25.71 | |
| 188,641 | 720,210 | 26.19 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| ALLK – Allakos Inc. | ALLO – Allogene Therapeutics, Inc. |
| ALNY – Alnylam Pharmaceuticals, Inc. | AMGN – Amgen Inc. |
| AMLX – Amylyx Pharmaceuticals, Inc. |
Financial data and stock pages provided by
Fintel.io